When you stay in a hospital overnight, every pill you swallow gets logged, coded, and billed. A single tablet of amlodipine (a common blood pressure drug) that costs a pharmacy roughly $0.23 to acquire has appeared on hospital chargemasters at $43.05, a markup of 18,617%. A niacin pill that retails for about a nickel has been billed at $24.00. Saline IV bags that hospitals purchase for under $2 show up on patient bills at $700 or more.
These numbers are not typos. They come from a 2021 analysis of hospital chargemaster prices published by researchers using CMS transparency data and a range of peer-reviewed studies. As of 2026, the practice has only intensified, and most patients never notice because the bill arrives weeks after discharge when the experience feels like ancient history.
Quick Answer: Inpatient drug markups in U.S. hospitals frequently range from 300% to 18,000%+ above the hospital's actual acquisition cost, according to CMS data and peer-reviewed research. The markups are set via chargemaster pricing and vary wildly by hospital, drug type, and payer. You have the legal right to an itemized bill and to dispute any charge. The CoveredUSA Bill Analyzer can flag suspicious drug line items in about 30 seconds.
What Is the Chargemaster and Why Does It Exist?
The chargemaster, officially called the charge description master or CDM, is a hospital's internal price list. It contains a code and a sticker price for every drug, procedure, supply, and service the facility provides. Most hospitals have chargemasters with tens of thousands of line items.
The chargemaster price is the "list price", the number before any insurance negotiation. Insurers negotiate it down. Medicare and Medicaid pay fixed rates set by the federal government, regardless of what the chargemaster says. Uninsured and underinsured patients, on the other hand, are often billed at or near the full chargemaster price.
This creates a split world:
- A commercially insured patient with a good PPO might pay 40-60% of the chargemaster rate after negotiation.
- A Medicare patient pays a federally fixed amount (CMS limits drug add-ons to 6% above acquisition cost for many hospital outpatient drugs).
- An uninsured patient often receives a bill at the full chargemaster rate, the highest possible number.
There is no federal law that caps what a hospital can put in its chargemaster. Hospitals set their own list prices, and many have increased them year-over-year to preserve margin after insurance discounts.
How Big Are the Markups in 2026?
The data is striking. Based on publicly available chargemaster files and peer-reviewed literature:
| Drug Type | Typical Hospital Acquisition Cost | Typical Chargemaster Charge | Markup Range |
|---|
| Generic tablet (e.g., aspirin, niacin) | $0.01 to $0.50 | $5 to $100+ | 1,000% to 18,000%+ |
| Saline IV (1 liter) | $1 to $2 | $100 to $700+ | 5,000% to 35,000% |
| Specialty infusion (e.g., chemotherapy) | Varies | 2.5x to 6.59x insurer average | 150% to 559% above ASP |
| Brand-name oral drug | Varies | 2x to 5x wholesale acquisition cost | 100% to 400% |
A 2024 study published in the New England Journal of Medicine found that hospitals eligible for the federal 340B drug discount program charged private insurers at a median markup of 3.08x, and retained nearly two-thirds of all insurer drug expenditures themselves. Hospitals not eligible for 340B discounts imposed markups averaging 2.4x above their acquisition costs. Physician practices, by comparison, applied far smaller markups on the same drugs.
The American Hospital Association disputes characterizing these as "markups," arguing that list prices account for overhead, uncompensated care, and cross-subsidization of underpaying government programs. Regardless of the justification, patients who receive bills at chargemaster rates face numbers that have no direct relationship to what the drug actually cost.
According to ASPE (HHS Office of the Assistant Secretary for Planning and Evaluation), drug spending is one of the fastest-growing cost drivers across all payer types. The problem is structural, not accidental.
Why Inpatient Drug Bills Are Especially Prone to Errors
When you are admitted to a hospital as an inpatient, the billing environment becomes especially complex. Reasons include:
Unit-dose billing. Inpatient pharmacies dispense drugs one dose at a time. Each dose gets a separate billing line. A five-day course of antibiotics may generate 15 separate drug line items, each billed at chargemaster rates.
Returned or wasted doses. If a drug was ordered but you did not receive it, or a dose was drawn up and then discarded, it may still appear on your bill. Up to 80% of hospital bills contain at least one error, according to research cited by Orbdoc.
Upcoding. A lower-cost generic is substituted during your stay, but the brand-name code is entered. You pay brand-name rates.
Duplicate charges. The same drug appears twice on the same day because it was entered in two separate nursing systems.
PRN ("as needed") medications. Drugs ordered on a standby basis but not actually administered sometimes get billed anyway.
None of these errors will be visible on a summary bill. You must request an itemized statement to see individual drug charges by name, date, dose, and CPT or NDC code.
What Inpatient Drug Markup Percentages Look Like in Practice
The 2021 chargemaster spread analysis found a 5-mg tablet of amlodipine ranging from $0.23 to $43.05 across different hospitals, a spread of over 18,617%. The same study found aspirin tablets ranging from a few cents to over $10 per tablet, and IV acetaminophen (Ofirmev) showing similar extreme variation.
These are not theoretical numbers. They appear on real patients' real bills.
Using the CoveredUSA Bill Analyzer, you can upload your itemized hospital bill and the tool compares each drug line item against Medicare reimbursement rates, the most transparent, publicly available drug pricing benchmark in the U.S. healthcare system. If a charge is wildly above the Medicare rate, that is a red flag worth disputing.
How Hospitals Justify Extreme Markups
Hospitals offer several explanations for chargemaster pricing:
-
The chargemaster is just a starting point. Hospitals argue that almost no one pays the list price because insurers negotiate it down. True for insured patients, not true for the uninsured or for self-pay patients.
-
Drug handling and storage costs. Hospitals cite pharmacy overhead: pharmacists, automated dispensing machines, cold chain storage, regulatory compliance. These costs are real, but rarely justify 10,000% markups on a $0.05 pill.
-
Cross-subsidization. Hospitals use high commercial prices to offset low Medicare and Medicaid payment rates. This is a structural argument about systemic underfunding, not a patient-facing defense.
-
340B program dynamics. Hospitals that qualify for 340B can acquire drugs at steep discounts (sometimes 50%+ below wholesale) while billing insurers at full price. The NEJM study found these hospitals retained the largest share of insurer drug spending, essentially pocketing the spread.
Your Rights When You Receive an Inpatient Drug Bill
As of 2026, several federal laws protect patients facing hospital drug overcharges:
Hospital Price Transparency Rule (effective 2021, enforcement ramped up in 2025). Hospitals must post machine-readable chargemaster files and consumer-facing price lists online. A 2024 HHS OIG audit found that 37 out of 100 sampled hospitals still did not comply. An executive order signed in February 2025 directed agencies to escalate enforcement within 90 days.
Right to an Itemized Bill. Federal law requires hospitals to provide an itemized bill within 30 days of request, at no cost. This is the document you need to find drug-level overcharges.
Right to Dispute. CMS provides a formal medical bill dispute process. You can also dispute directly with the hospital's billing department, patient advocate, or CFO office.
Charity Care for Nonprofit Hospitals. Under IRS Section 501(r), every nonprofit hospital must offer a financial assistance program. Many cover patients earning up to 300-400% of the federal poverty level. For 2026, that means a household of four with income up to roughly $132,000 may qualify for free or reduced-cost care, including reduction of inflated drug charges.
How to Dispute Inpatient Drug Charges: Step-by-Step
If you received an inpatient bill that includes drug charges you want to challenge, follow these steps:
Documents you will need:
- Itemized hospital bill (request specifically; the summary bill is not enough)
- Explanation of Benefits (EOB) from your insurer
- Hospital's posted chargemaster or price transparency file
- Your medical records (particularly the medication administration record)
- Any 835 payment remittance advice if available
Step 1: Request your itemized bill in writing. Call the billing department and follow up in writing. Ask for the bill broken down by CPT code, NDC code (for drugs), date of service, and quantity.
Step 2: Compare drug charges against the Medicare rate. CMS publishes Average Sales Price (ASP) data quarterly. If a hospital billed you 10x the Medicare rate for a common drug, that is a documented overcharge.
Step 3: Upload your bill to the CoveredUSA Bill Analyzer. Upload your hospital bill to the free CoveredUSA Bill Analyzer to find errors, overcharges, and charity care options in 30 seconds. The tool flags line items that deviate significantly from benchmark rates so you know exactly which charges to challenge.
Step 4: File a formal dispute. Submit a written dispute to the hospital billing department. Reference the specific line items, the Medicare benchmark, and the hospital's posted price transparency data if available. Keep a paper trail.
Step 5: Escalate if needed. If the billing department rejects your dispute, escalate to the hospital's patient advocate, CFO office, or state attorney general consumer protection division. Georgia, for example, maintains a dedicated consumer protection unit for hospital billing complaints.
Step 6: Apply for financial assistance. Even if the charges are "correct" by the hospital's own rules, you may qualify for charity care that reduces or eliminates the bill entirely. Ask for a financial assistance application simultaneously with your dispute.
Common reasons disputes are rejected (and how to counter them):
- "You signed a financial agreement at admission." This does not waive your right to dispute specific charges.
- "The chargemaster price is standard." Standard does not mean correct or legally required.
- "Insurance already negotiated the price." Check your EOB; the insurer may have been overcharged too, and the remaining patient responsibility may reflect that error.
- "It was administered as ordered." That may be true, but if the drug was wasted or returned, it should not appear on your bill.
A JAMA Health Forum study found that among patients who disputed a billing error, nearly three-quarters had the mistake corrected. About 62% of those who asked about an unaffordable bill received a payment plan or price reduction.
Frequently Asked Questions
What is the average inpatient drug markup percentage at U.S. hospitals?
As of 2026, average hospital markups across all services run roughly $432 charged per $100 of actual cost. For-profit hospitals average closer to $631 per $100. Drug-specific markups range much wider, from 100% above acquisition cost for some specialty drugs up to 18,000%+ for generic pills and IV fluids, based on chargemaster spread analyses.
How do I find out what my hospital actually paid for a drug?
Hospitals are not required to publish their acquisition costs, but they are required to publish chargemaster prices. The gap between chargemaster prices at different hospitals for the same drug, available via federal price transparency data, gives you a sense of how high one hospital's pricing is relative to others. CMS also publishes Average Sales Price (ASP) data quarterly for Part B drugs, which is the closest public benchmark to what hospitals actually pay.
Are inpatient drug charges regulated by the federal government?
Medicare sets fixed payment rates for hospital inpatient stays via the inpatient prospective payment system (IPPS). Most drug costs are bundled into the diagnosis-related group (DRG) payment, meaning Medicare pays a fixed amount for the whole stay, not line-by-line drug charges. For commercially insured patients, there is no federal cap on chargemaster drug prices. The 2021 Hospital Price Transparency Rule requires disclosure, not price limits.
What is the 340B program and why does it affect my bill?
The 340B Drug Pricing Program allows qualifying hospitals (those serving low-income populations) to purchase drugs from manufacturers at discounts of 25-50% or more below wholesale. The hospitals then bill insurers and patients at full chargemaster rates. The spread between the discounted acquisition cost and the billed amount can be substantial. The NEJM found 340B hospitals retained about two-thirds of all insurer drug expenditures, passing only one-third to manufacturers.
Can I dispute drug charges on my hospital bill myself?
Yes. You do not need a lawyer or professional advocate, though both can help. Request an itemized bill, compare charges to public benchmarks, write a formal dispute letter, and follow up. Three out of four people who dispute billing errors get them corrected, per JAMA data.
What is charity care and do I qualify?
Every nonprofit hospital must offer charity care under IRS 501(r). Eligibility thresholds vary by hospital; many cover patients at 200-400% of the federal poverty level. For 2026, 400% FPL for a family of four is approximately $132,000. Even middle-income patients sometimes qualify. Always apply for financial assistance at the same time you dispute charges, as the two processes can run in parallel.
Does the CoveredUSA Bill Analyzer cost anything?
No. The CoveredUSA Bill Analyzer is free to use. Upload your hospital bill and the tool compares each line item against Medicare benchmark rates. It takes about 30 seconds and identifies specific charges that are likely errors or overcharges worth challenging.
What if my insurer already paid, does the markup still matter to me?
Yes. Your share of the bill (deductibles, coinsurance, copays) is typically calculated as a percentage of the billed (chargemaster) amount, not the Medicare rate. If the hospital billed $10,000 for drugs and your coinsurance is 20%, you owe $2,000. If the correct charge should have been $3,000, your share should be $600. The markup affects your out-of-pocket cost directly, not just the insurer's payment.
